Galectin Therapeutics Inc

Geneos Wealth Management Inc. GALT

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

243,327

Value ($000)

1,012

Weight

0.0%

2016 Q1 - 2025 Q4 (40 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	1,012	0.0%	243,327	12/31/2025
2025 Q3	10/22/2025	1,527	0.0%	360,175	9/30/2025
2025 Q2	8/18/2025	893	0.0%	423,235	6/30/2025
2025 Q1	5/8/2025	521	0.0%	427,435	3/31/2025
2024 Q4	1/21/2025	502	0.0%	388,935	12/31/2024
2024 Q3	11/14/2024	971	0.0%	352,935	9/30/2024
2024 Q2	7/23/2024	890	0.0%	393,725	6/30/2024
2024 Q1	5/3/2024	977	0.0%	408,850	3/31/2024
2023 Q4	1/26/2024	685	0.0%	412,650	12/31/2023
2023 Q3	10/11/2023	801	0.0%	417,350	9/30/2023
2023 Q2	8/8/2023	607	0.0%	421,650	6/30/2023
2023 Q1	4/25/2023	898	0.1%	427,400	3/31/2023
2022 Q4	1/31/2023	491	0.0%	434,800	12/31/2022
2022 Q3	11/14/2022	725	0.0%	445,200	9/30/2022
2022 Q2	7/22/2022	626	0.0%	478,067	6/30/2022
2022 Q1	5/16/2022	764	0.0%	474,767	3/31/2022
2021 Q4	2/9/2022	995	0.0%	480,767	12/31/2021
2021 Q3	11/9/2021	1,867	0.1%	491,367	9/30/2021
2021 Q2	7/8/2021	1,560	0.1%	492,267	6/30/2021
2021 Q1	6/17/2021	2,261	0.1%	511,606	3/31/2021
2020 Q4	5/19/2021	961	0.0%	485,606	12/31/2020
2020 Q3	9/7/2021	101	0.0%	37,017	9/30/2020
2020 Q2	9/7/2021	108	0.0%	37,017	6/30/2020
2020 Q1	9/7/2021	80	0.0%	41,750	3/31/2020
2019 Q4	9/7/2021	126	0.0%	43,750	12/31/2019
2019 Q3	9/7/2021	160	0.0%	44,150	9/30/2019
2019 Q2	9/7/2021	220	0.0%	53,150	6/30/2019
2019 Q1	9/7/2021	284	0.0%	55,650	3/31/2019
2018 Q4	9/7/2021	224	0.0%	59,650	12/31/2018
2018 Q3	9/7/2021	358	0.0%	59,650	9/30/2018
2018 Q2	9/7/2021	78	0.0%	12,350	6/30/2018
2018 Q1	9/7/2021	196	0.0%	41,390	3/31/2018
2017 Q4	9/7/2021	245	0.0%	73,485	12/31/2017
2017 Q3	9/7/2021	146	0.0%	68,612	9/30/2017
2017 Q2	9/7/2021	149	0.0%	60,612	6/30/2017
2017 Q1	9/7/2021	130	0.0%	56,612	3/31/2017
2016 Q4	9/7/2021	51	0.0%	52,612	12/31/2016
2016 Q3	9/7/2021	57	0.0%	50,812	9/30/2016
2016 Q2	9/7/2021	77	0.0%	50,812	6/30/2016
2016 Q1	9/7/2021	73	0.0%	50,812	3/31/2016